Source: OHIO STATE UNIVERSITY - VET MED submitted to NRP
EFFICACY STUDIES OF FORT DODGE'S SARCOCYSTIS NEURONA VACCINE
Sponsoring Institution
National Institute of Food and Agriculture
Project Status
COMPLETE
Funding Source
Reporting Frequency
Annual
Accession No.
0201820
Grant No.
(N/A)
Cumulative Award Amt.
(N/A)
Proposal No.
(N/A)
Multistate No.
(N/A)
Project Start Date
Sep 1, 2003
Project End Date
Mar 31, 2005
Grant Year
(N/A)
Program Code
[(N/A)]- (N/A)
Recipient Organization
OHIO STATE UNIVERSITY - VET MED
1900 COFFEY ROAD, 127L VMAB
COLUMBUS,OH 43210
Performing Department
PREVENTIVE MEDICINE
Non Technical Summary
Neurologic disease, such as Equine Protozoal Myeloencephalitis, is caused by exposure to Sarcocystis neurona. This project will aid in finding a vaccination for healthy horses to aid in prevention of neurologic disease (EPM) caused by subsequent exposure to the protozoan Sarcocystis neurona.
Animal Health Component
100%
Research Effort Categories
Basic
(N/A)
Applied
100%
Developmental
(N/A)
Classification

Knowledge Area (KA)Subject of Investigation (SOI)Field of Science (FOS)Percent
31138101180100%
Knowledge Area
311 - Animal Diseases;

Subject Of Investigation
3810 - Horses, ponies, and mules;

Field Of Science
1180 - Pharmacology;
Goals / Objectives
To evaluate the efficacy of FDAH's Sarcocystis neurona Vaccine, Killed Protozoa.
Project Methods
Horses will be screened by Western blots for antibody to S. neurona. Prior to vaccination, all horses will receive physical and neurologic exams. At least 35 seronegative and clinically normal horses will be selected for vaccination. Horses vaccinated with the S. neurona vaccine will be transported to FDAH and examined physically and neurologically. 30 of those horses will be selected for the challenge phase of the study. Two groups of 15 horses. Group 1 will be vaccinated intramuscularly with two doses of the test vaccine (1 mL/dose), three to four weeks apart. Group 2 will receive a placebo. Serum samples will be collected at 0 DPV1, 14 DPV2, 0 DPV2, 21 DPV2, and 0 DPC for the determination of antibody titer to S. neurona by IFA. Each horse will be sedated with Sedazine and Torbogesic for CSF collection. CSF samples will be taken by standing lumbrosacral puncture method of collection prior to vaccination. S. neurona sporocysts will be obtained from laboratory raised opossums fed tissues of raccoons that were fed sporocysts. Following challenge, the horses will be examined weekly by the blinded observer for neurologic deficits.

Progress 09/01/03 to 03/31/05

Outputs
The PI has informed me that at this time he cannot report on anything regarding this study. This is a directive from the company.

Impacts
Nothing to report at this time.

Publications

  • No publications reported this period